574 related articles for article (PubMed ID: 33106634)
1. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis and risk for hematologic malignancy.
Warren JT; Link DC
Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
[TBL] [Abstract][Full Text] [Related]
3. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Rosenberg CA; Bill M; Kerndrup GB; Ebbesen LH; Hansen MH; Roug AS; Ludvigsen M
Bone Marrow Transplant; 2022 Mar; 57(3):460-465. PubMed ID: 35027675
[TBL] [Abstract][Full Text] [Related]
4. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
5. Mutant
Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
[TBL] [Abstract][Full Text] [Related]
6. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
7. Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.
Gao T; Ptashkin R; Bolton KL; Sirenko M; Fong C; Spitzer B; Menghrajani K; Ossa JEA; Zhou Y; Bernard E; Levine M; Martinez JSM; Zhang Y; Franch-Expósito S; Patel M; Braunstein LZ; Kelly D; Yabe M; Benayed R; Caltabellotta NM; Philip J; Paraiso E; Mantha S; Solit DB; Diaz LA; Berger MF; Klimek V; Levine RL; Zehir A; Devlin SM; Papaemmanuil E
Nat Commun; 2021 Jan; 12(1):338. PubMed ID: 33436578
[TBL] [Abstract][Full Text] [Related]
8. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
Sant'Antonio E; Camerini C; Rizzo V; Musolino C; Allegra A
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):573-579. PubMed ID: 34078586
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
Xu E; Su K; Zhou Y; Gong L; Xuan Y; Liao M; Cao J; Li Y; Lu Y; Zhao Y; Chen F
J Cell Mol Med; 2021 Nov; 25(21):10279-10290. PubMed ID: 34658138
[TBL] [Abstract][Full Text] [Related]
10. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
12. High frequency of clonal hematopoiesis in Erdheim-Chester disease.
Cohen Aubart F; Roos-Weil D; Armand M; Marceau-Renaut A; Emile JF; Duployez N; Charlotte F; Poulain S; Lhote R; Hélias-Rodzewicz Z; Della-Valle V; Bernard O; Maloum K; Nguyen-Khac F; Donadieu J; Amoura Z; Abdel-Wahab O; Haroche J
Blood; 2021 Jan; 137(4):485-492. PubMed ID: 33067622
[TBL] [Abstract][Full Text] [Related]
13. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.
Saygin C; Zhang P; Stauber J; Aldoss I; Sperling AS; Weeks LD; Luskin MR; Knepper TC; Wanjari P; Wang P; Lager AM; Fitzpatrick C; Segal JP; Gharghabi M; Gurbuxani S; Venkataraman G; Cheng JX; Eisfelder BJ; Bohorquez O; Patel AA; Umesh Nagalakshmi S; Jayaram S; Odenike OM; Larson RA; Godley LA; Arber DA; Gibson CJ; Munshi NC; Marcucci G; Ebert BL; Greally JM; Steidl U; Lapalombella R; Shah BD; Stock W
Blood Cancer Discov; 2024 May; 5(3):164-179. PubMed ID: 38150184
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract][Full Text] [Related]
15. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.
Hong W; Li A; Liu Y; Xiao X; Christiani DC; Hung RJ; McKay J; Field J; Amos CI; Cheng C
Cancer Res; 2022 Jan; 82(2):199-209. PubMed ID: 34815255
[TBL] [Abstract][Full Text] [Related]
16. Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
Diamond B; Ziccheddu B; Maclachlan K; Taylor J; Boyle E; Ossa JA; Jahn J; Affer M; Totiger TM; Coffey D; Chandhok N; Watts J; Cimmino L; Lu SX; Bolli N; Bolton K; Landau H; Park JH; Ganesh K; McPherson A; Sekeres MA; Lesokhin A; Chung DJ; Zhang Y; Ho C; Roshal M; Tyner J; Nimer S; Papaemmanuil E; Usmani S; Morgan G; Landgren O; Maura F
Blood; 2023 May; 141(19):2359-2371. PubMed ID: 36626250
[TBL] [Abstract][Full Text] [Related]
17. Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.
Eskelund CW; Husby S; Favero F; Klausen TW; Rodriguez-Gonzalez FG; Kolstad A; Pedersen LB; Räty RK; Geisler CH; Jerkeman M; Weischenfeldt J; Grønbæk K
Blood; 2020 May; 135(22):2000-2004. PubMed ID: 32181815
[No Abstract] [Full Text] [Related]
18. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms.
Jahn J; Diamond B; Hsu J; Montoya S; Totiger TM; Landgren O; Maura F; Taylor J
Leuk Res; 2023 Mar; 126():107020. PubMed ID: 36696829
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis is associated with risk of severe Covid-19.
Bolton KL; Koh Y; Foote MB; Im H; Jee J; Sun CH; Safonov A; Ptashkin R; Moon JH; Lee JY; Jung J; Kang CK; Song KH; Choe PG; Park WB; Kim HB; Oh MD; Song H; Kim S; Patel M; Derkach A; Gedvilaite E; Tkachuk KA; Wiley BJ; Chan IC; Braunstein LZ; Gao T; Papaemmanuil E; Esther Babady N; Pessin MS; Kamboj M; Diaz LA; Ladanyi M; Rauh MJ; Natarajan P; Machiela MJ; Awadalla P; Joseph V; Offit K; Norton L; Berger MF; Levine RL; Kim ES; Kim NJ; Zehir A
Nat Commun; 2021 Oct; 12(1):5975. PubMed ID: 34645798
[TBL] [Abstract][Full Text] [Related]
20. The crossroads of cancer therapies and clonal hematopoiesis.
Singh A; Balasubramanian S
Semin Hematol; 2024 Feb; 61(1):16-21. PubMed ID: 38403501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
